Clinical trial

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

NCT02619448

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-12-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2014-12-01Date precision: month

Registry last updated2024-03-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

CarboplatinDRUG · verified · RxNorm: carboplatin

PaclitaxelDRUG · verified · RxNorm: paclitaxel

70 Gy in 20 fractions over 4 weeksRADIATION

Sponsors & collaborators

State University of New York - Upstate Medical Universitylead sponsor

Mapped research locations

SyracuseNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02619448 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.